Evidence map›Paper›PMID 38572490›Full record

ArticleFrontiers in neurology2024

Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease.

Carmela Romano, Emanuele Morena, Simona Petrucci, Selene Diamant, Martina Marconi, Lorena Travaglini, Ginevra Zanni, Maria Piane, Marco Salvetti, Silvia Romano and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Carmela RomanoDepartment of Human Neurosciences, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Emanuele MorenaDepartment of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Simona PetrucciDepartment of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
Selene DiamantDepartment of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Martina MarconiDepartment of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Lorena TravagliniLaboratory of Medical Genetics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Ginevra ZanniGenetics and Rare Diseases Research Division, Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Maria PianeDepartment of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
Marco SalvettiDepartment of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Silvia RomanoDepartment of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Giovanni RistoriDepartment of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Azienda Ospedaliera Sant'Andrea · ITBambino Gesù Children's Hospital · ITCTO Andrea Alesini · ITFondazione Santa Lucia · ITIstituto Neurologico Mediterraneo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alexander disease (AxD) is a rare inherited autosomal dominant (AD) disease with different clinical phenotypes according to the age of onset. It is caused by mutations in the glial fibrillary acid protein (GFAP) gene, which causes GFAP accumulation in astrocytes. A wide spectrum of mutations has been described. For some variants, genotype-phenotype correlations have been described, although variable expressivity has also been reported in late-onset cases among members of the same family. We present the case of a 19-year-old girl who developed gait ataxia and subtle involuntary movements, preceded by a history of enuresis and severe scoliosis. Her mother has been affected by ataxia since her childhood, which was then complicated by pyramidal signs and heavily worsened through the years. Beyond her mother, no other known relatives suffered from neurologic syndromes. The scenario was further complicated by a complex brain and spinal cord magnetic resonance imaging (MRI) pattern in both mother and daughter. However, the similar clinical phenotype made an inherited cause highly probable. Both AD and autosomal recessive (AR) ataxic syndromes were considered, lacking a part of the proband's pedigree, but no causative genetic alterations were found. Considering the strong suspicion for an inherited condition, we performed clinical exome sequencing (CES), which analyzes more than 4,500 genes associated with diseases. CES evidenced the new heterozygous missense variant c.260 T > A in exon 1 of the glial fibrillary acidic protein (GFAP) gene (NM_002055.4), which causes the valine to aspartate amino acid substitution at codon 87 (p. Val87Asp) in the GFAP. The same heterozygous variant was detected in her mother. This mutation has never been described before in the literature. This case should raise awareness for this rare and under-recognized disease in juvenile-adult cases.

Indexed as

Alexander diseaseastrocytesataxiaGFAP mutationleukodystrophy

Identifiers

PMID38572490
PMCPMC10987758
OpenAlexW4393014213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.